Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1950 1
1951 3
1953 2
1957 1
1961 1
1962 1
1963 1
1964 1
1965 1
1966 1
1967 2
1968 1
1969 4
1970 4
1971 3
1972 6
1973 6
1974 5
1975 10
1976 9
1977 8
1978 6
1979 5
1980 6
1981 5
1982 9
1983 6
1984 9
1985 8
1986 6
1987 14
1988 11
1989 8
1990 12
1991 14
1992 7
1993 9
1994 21
1995 16
1996 15
1997 9
1998 11
1999 10
2000 3
2001 1
2002 4
2003 3
2004 6
2005 6
2006 2
2007 4
2008 1
2009 7
2010 5
2011 6
2012 4
2013 3
2014 3
2015 3
2016 2
2017 7
2018 5
2019 9
2020 13
2021 7
2022 13
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Results by year

Filters applied: . Clear all
Page 1
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia.
Daver N, Perl AE, Maly J, Levis M, Ritchie E, Litzow M, McCloskey J, Smith CC, Schiller G, Bradley T, Tiu RV, Naqvi K, Dail M, Brackman D, Siddani S, Wang J, Chyla B, Lee P, Altman JK. Daver N, et al. Among authors: mccloskey j. J Clin Oncol. 2022 Dec 10;40(35):4048-4059. doi: 10.1200/JCO.22.00602. Epub 2022 Jul 18. J Clin Oncol. 2022. PMID: 35849791 Free PMC article. Clinical Trial.
Education News.
Scott-Herring M, Mendez A, Shay J, McCloskey J, Koka R. Scott-Herring M, et al. Among authors: mccloskey j. AANA J. 2019 Apr;87(2):7-14. AANA J. 2019. PMID: 31587730
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study.
Garcia-Manero G, Griffiths EA, Steensma DP, Roboz GJ, Wells R, McCloskey J, Odenike O, DeZern AE, Yee K, Busque L, O'Connell C, Michaelis LC, Brandwein J, Kantarjian H, Oganesian A, Azab M, Savona MR. Garcia-Manero G, et al. Among authors: mccloskey j. Blood. 2020 Aug 6;136(6):674-683. doi: 10.1182/blood.2019004143. Blood. 2020. PMID: 32285126 Free PMC article. Clinical Trial.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Cortes J, Apperley J, Lomaia E, Moiraghi B, Undurraga Sutton M, Pavlovsky C, Chuah C, Sacha T, Lipton JH, Schiffer CA, McCloskey J, Hochhaus A, Rousselot P, Rosti G, de Lavallade H, Turkina A, Rojas C, Arthur CK, Maness L, Talpaz M, Mauro M, Hall T, Lu V, Srivastava S, Deininger M. Cortes J, et al. Among authors: mccloskey j. Blood. 2021 Nov 25;138(21):2042-2050. doi: 10.1182/blood.2021012082. Blood. 2021. PMID: 34407543 Free PMC article. Clinical Trial.
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Stein EM, DiNardo CD, Fathi AT, Mims AS, Pratz KW, Savona MR, Stein AS, Stone RM, Winer ES, Seet CS, Döhner H, Pollyea DA, McCloskey JK, Odenike O, Löwenberg B, Ossenkoppele GJ, Patel PA, Roshal M, Frattini MG, Lersch F, Franovic A, Nabhan S, Fan B, Choe S, Wang H, Wu B, Hua L, Almon C, Cooper M, Kantarjian HM, Tallman MS. Stein EM, et al. Among authors: mccloskey jk. Blood. 2021 Apr 1;137(13):1792-1803. doi: 10.1182/blood.2020007233. Blood. 2021. PMID: 33024987 Free PMC article. Clinical Trial.
When Is it Best to "BURP"?
McCloskey JJ, Schwartz JM, Shaffner DH. McCloskey JJ, et al. Pediatr Crit Care Med. 2018 Feb;19(2):162-163. doi: 10.1097/PCC.0000000000001389. Pediatr Crit Care Med. 2018. PMID: 29394224 No abstract available.
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study.
Garcia-Manero G, McCloskey J, Griffiths EA, Yee KWL, Zeidan AM, Al-Kali A, Deeg HJ, Patel PA, Sabloff M, Keating MM, Zhu N, Gabrail NY, Fazal S, Maly J, Odenike O, Kantarjian H, DeZern AE, O'Connell CL, Roboz GJ, Busque L, Buckstein R, Amin H, Randhawa J, Leber B, Shastri A, Dao KH, Oganesian A, Hao Y, Keer HN, Azab M, Savona MR. Garcia-Manero G, et al. Among authors: mccloskey j. Lancet Haematol. 2024 Jan;11(1):e15-e26. doi: 10.1016/S2352-3026(23)00338-1. Lancet Haematol. 2024. PMID: 38135371 Clinical Trial.
Leadership in nursing.
McCloskey JC, Molen MT. McCloskey JC, et al. Annu Rev Nurs Res. 1987;5:177-202. Annu Rev Nurs Res. 1987. PMID: 3555553 Review. No abstract available.
Video Laryngoscopy: What We Can See and What We Cannot.
Schwartz JM, McCloskey JJ, Shaffner DH. Schwartz JM, et al. Among authors: mccloskey jj. Pediatr Crit Care Med. 2017 May;18(5):491-492. doi: 10.1097/PCC.0000000000001141. Pediatr Crit Care Med. 2017. PMID: 28475534 No abstract available.
Modelling and quantifying tomorrow's risks from natural hazards.
Cremen G, Galasso C, McCloskey J. Cremen G, et al. Among authors: mccloskey j. Sci Total Environ. 2022 Apr 15;817:152552. doi: 10.1016/j.scitotenv.2021.152552. Epub 2021 Dec 22. Sci Total Environ. 2022. PMID: 34952074 Free article. Review.
410 results